We are live on ! Find out more
Federated Hermes

Federated Hermes Portfolio holdings

AUM $69.6B
1-Year Est. Return 42.52%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$43.4B
AUM Growth
+$3.14B
Cap. Flow
-$115M
Cap. Flow %
-0.27%
Top 10 Hldgs %
13.22%
Holding
2,192
New
164
Increased
795
Reduced
936
Closed
172

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$189M
2
WMB icon
Williams Companies
WMB
+$155M
3
AYX
Alteryx Inc
AYX
+$94.1M
4
ABBV icon
AbbVie
ABBV
+$87M
5
AMGN icon
Amgen
AMGN
+$78.1M

Sector Composition

Rank Sector Weight
1 Technology 17.44%
2 Healthcare 17.1%
3 Financials 12.78%
4 Industrials 10.38%
5 Consumer Discretionary 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TYL icon
126
Tyler Technologies
TYL
$14.7B
$89.7M 0.21%
211,024
+72,479
+52% +$31M
PANW icon
127
Palo Alto Networks
PANW
$306B
$88.8M 0.2%
625,064
-101,202
-14% -$16M
MELI icon
128
Mercado Libre
MELI
$96.3B
$88.7M 0.2%
58,640
+34,787
+146% +$56.9M
VRTX icon
129
Vertex Pharmaceuticals
VRTX
$132B
$88.6M 0.2%
211,915
+6,554
+3% +$2.77M
UBER icon
130
Uber
UBER
$148B
$88M 0.2%
1,142,620
+641,120
+128% +$46M
ATR icon
131
AptarGroup
ATR
$7.94B
$87.7M 0.2%
609,245
+21,605
+4% +$2.93M
RPM icon
132
RPM International
RPM
$12.9B
$87.5M 0.2%
735,579
+46,734
+7% +$5.2M
RGA icon
133
Reinsurance Group of America
RGA
$16.3B
$87.3M 0.2%
452,586
+15,169
+3% +$2.65M
LEGN icon
134
Legend Biotech
LEGN
$3.6B
$86.2M 0.2%
1,537,060
-188,912
-11% -$11.4M
RCL icon
135
Royal Caribbean
RCL
$68.3B
$85.4M 0.2%
614,371
-24,977
-4% -$3.12M
BZ icon
136
Kanzhun
BZ
$6.92B
$85.2M 0.2%
+4,861,533
New +$76.7M
GTLS
137
DELISTED
Chart Industries
GTLS
$84.7M 0.2%
514,499
-79,890
-13% -$10.7M
WTFC icon
138
Wintrust Financial
WTFC
$10.3B
$83.7M 0.19%
801,379
+12,764
+2% +$1.23M
XOM icon
139
ExxonMobil
XOM
$679B
$83.6M 0.19%
719,034
+225,499
+46% +$23.6M
ATI icon
140
ATI
ATI
$25.6B
$83.5M 0.19%
1,631,836
+372,867
+30% +$16.9M
LULU icon
141
lululemon athletica
LULU
$11.1B
$83.2M 0.19%
212,952
+2,751
+1% +$1.27M
ARES icon
142
Ares Management
ARES
$29.9B
$83.1M 0.19%
625,000
INTU icon
143
Intuit
INTU
$90.6B
$82.7M 0.19%
127,272
+12,322
+11% +$7.87M
TCOM icon
144
Trip.com Group
TCOM
$24.6B
$80.9M 0.19%
1,842,213
+404,446
+28% +$16.4M
PTC icon
145
PTC
PTC
$14.8B
$80M 0.18%
423,430
+17,234
+4% +$3.1M
BC icon
146
Brunswick
BC
$4.54B
$79.6M 0.18%
824,852
+22,560
+3% +$1.98M
MPC icon
147
Marathon Petroleum
MPC
$111B
$79.6M 0.18%
395,038
-137,152
-26% -$23.5M
VICI icon
148
VICI Properties
VICI
$27.6B
$79M 0.18%
2,652,087
-155,906
-6% -$4.68M
SRPT icon
149
Sarepta Therapeutics
SRPT
$2.21B
$79M 0.18%
610,216
-98,174
-14% -$12M
CLH icon
150
Clean Harbors
CLH
$17B
$77.9M 0.18%
387,182
+228
+0.1% +$41K

Similar funds

Federated Hermes's Q1 2024 Portfolio in Review

As of Q1 2024, Federated Hermes held 2,192 positions worth $43.4B, up 7.8% from $40.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Federated Hermes's Q1 2024 filing shows 164 new, 795 increased, 936 reduced and 172 closed positions. Its largest new stake was Kanzhun: 4,861,533 shares worth $85.2M. The largest sale was Medtronic, an estimated $189M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

  • Federated Hermes's largest Q1 2024 buy was Kanzhun: 4,861,533 shares worth $85.2M.
  • Federated Hermes added most to Bristol-Myers Squibb in Q1 2024, an estimated $193M increase.
  • Federated Hermes's biggest Q1 2024 reduction was Medtronic, cutting an estimated $189M.
  • Federated Hermes fully exited Alteryx Inc in Q1 2024, selling an estimated $94.1M.
  • Federated Hermes's ten largest holdings make up 13% of its $43.4B portfolio in Q1 2024.
  • Federated Hermes opened 164 new positions and closed 172 in Q1 2024.
  • Federated Hermes's portfolio value rose 7.8% quarter-over-quarter to $43.4B.

Based on Federated Hermes's 13F filing for Q1 2024, filed 14 May 2024.